How should we fund the development of drugs to treat resistant diseases?

This article proposes that governments fund them to do the development, and later are entitled to the drug at a reasonable price. That could be good if all governments will be entitled to the drug at a reasonable price. But I suspect that all but the sponsoring country will have to pay through the nose.

Inviting Big Pharma companies in will surely mean letting them gouge. They will find an excuse, or simply insist.

I think that the drug-manufacturing know-how should be available to any country that either (1) is poor or (2) sponsors drug research appropriately for the size of its economy.